samedan logo

 
 
spacer
home > ict > spring 2016 > across the globe
PUBLICATIONS
International Clinical Trials

Across the Globe

The purpose of clinical trials is, simply put, to evaluate the effects of a drug on trial participants. It makes sense to involve participants from as many ethnic groups as possible, in order to assess the drug’s efficacy and announce it as safe for the public to use.

However, despite continuous efforts to globalise these trials, developing countries are still under-represented in clinical research – and there are a number of factors contributing to this siuation, like the lack of commercial viability and trained researchers, for example (1). Why is this contradictory? For one, the sheer population numbers in these countries means that there is a bigger patient pool available than in developed countries; furthermore, these potential patients might also be more willing to participate in a trial, and – in what is perhaps the most significant benefit of carrying out trials in remote locations – they can be recruited at substantially less cost compared to more affluent countries, as well as at a much faster rate (2).

References
1. Visit: www.journals.plos.org/plosmedicine/article?id=10.1371/ journal.pmed.1001228
2. Visit: www.fda.gov/downloads/training/ clinicalinvestigatortrainingcourse/ucm378499.pdf

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals initiates partnership with American Biotech Zhittya for Parkinson’s disease treatment

3P and Zhittya began their relationship at the beginning of 2019 with 3P being selected as the CDMO to transfer the process for scaling up and performing cGMP manufacturing for clinical studies. After successfully achieving transfer of the process, 3P anticipates manufacturing of the first cGMP batch by the second quarter of 2020.
More info >>

White Papers

Advantages of Quantitative NMR for the Determination of Relative Response Factors

Novatia, LLC

Quantitative NMR (qNMR) is a technique that is being applied broadly and at an increasing rate in the field of pharmaceutical analysis (1). This white paper highlights the advantages of using qNMR to determine Relative Response Factors (RRFs) for pharmaceutical impurities detectable by HPLC. A single determination of RRFs using qNMR allows for simple and accurate quantitation of impurities which eliminates the need for preparation, qualification, and storage of reference standards. An example is presented here, which demonstrates quantitation of known impurities that have variable responses to UV-VIS detection, thereby providing a more accurate assessment of impurity levels than UV-VIS response alone.
More info >>

 
Industry Events

SCOPE Summit for Clinical Ops Executives

18-21 February 2020, Hyatt Regency, Orlando, Florida, US

Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement